Diagnosis and Management of Non- Alcoholic Fatty Liver Disease

More documents

Recommendations

Info

Advanced fibrosis patients should be treated as cirrhotic patients • HCC screening – US or MRI Q6 months – AFP Q6 months • EGD for variceal screening Q1-3 years
Advanced fibrosis patients should be treated as cirrhotic patients • Monitoring for the complications <strong>of</strong> liver disease – Ascites – Encephalopathy • MELD labs to assess synthetic function – Cr, TB, INR • Referral to hepatologist
Page 1 and 2: Diagnosis and Management of Non- Al
Page 3 and 4: Case Presentation • AM is a 63M w
Page 5 and 6: Case Presentation: What is the most
Page 7 and 8: NAFLD: Spectrum of Hepatic Patholog
Page 9 and 10: Non-Alcoholic SteatoHepatitis (NASH
Page 11 and 12: How Many Americans Have NAFLD • 1
Page 13 and 14: Impact of NAFLD Wanless IR Hepatolo
Page 15 and 16: Dallas Heart Study Results Liver fa
Page 17 and 18: NAFLD in Type 2 Diabetes Mellitus
Page 19 and 20: What percentage of NASH patients ha
Page 21 and 22: Impact of NAFLD • NAFLD is associ
Page 23 and 24: • Who might have NAFLD Goal #1: D
Page 25 and 26: Goal #1: Determine the Etiology •
Page 27 and 28: Goal #1: Determine the Etiology •
Page 29 and 30: Goal #3: Determine Severity of Dise
Page 31 and 32: Who Needs a Liver Biopsy • Anyone
Page 33 and 34: • Steatosis • NASH - Lobular in
Page 35 and 36: Back to our Patient: What is the ne
Page 37 and 38: Weight loss & exercise are core of
Page 39: Pioglitazone is Beneficial In NASH
Page 43 and 44: • Please contact me with question
Page 45: NAFLD: Diagnostic Approach NAFLD: D

Diagnosis and Management of Non- Alcoholic Fatty Liver Disease

Create successful ePaper yourself

Delete template?

Save as template?